NGNE
Price
$17.09
Change
-$0.19 (-1.10%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
253.94M
RVXCF
Price
$0.03
Change
+$0.01 (+50.00%)
Updated
Mar 5 closing price
Capitalization
8.79M
Ad is loading...

NGNE vs RVXCF

Header iconNGNE vs RVXCF Comparison
Open Charts NGNE vs RVXCFBanner chart's image
Neurogene
Price$17.09
Change-$0.19 (-1.10%)
Volume$1K
Capitalization253.94M
Resverlogix
Price$0.03
Change+$0.01 (+50.00%)
Volume$10K
Capitalization8.79M
NGNE vs RVXCF Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. RVXCF commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and RVXCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (NGNE: $16.35 vs. RVXCF: $0.02)
Brand notoriety: NGNE and RVXCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 62% vs. RVXCF: 48%
Market capitalization -- NGNE: $253.94M vs. RVXCF: $8.79M
NGNE [@Biotechnology] is valued at $253.94M. RVXCF’s [@Biotechnology] market capitalization is $8.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileRVXCF’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • RVXCF’s FA Score: 1 green, 4 red.
According to our system of comparison, RVXCF is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 2 TA indicator(s) are bullish.

  • NGNE’s TA Score: 2 bullish, 7 bearish.

Price Growth

NGNE (@Biotechnology) experienced а -2.45% price change this week, while RVXCF (@Biotechnology) price change was -21.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($254M) has a higher market cap than RVXCF($8.79M). NGNE YTD gains are higher at: -28.478 vs. RVXCF (-36.299). RVXCF has higher annual earnings (EBITDA): -8.09M vs. NGNE (-49.96M). NGNE has more cash in the bank: 139M vs. RVXCF (43K). RVXCF has less debt than NGNE: RVXCF (8.95M) vs NGNE (14.5M). NGNE has higher revenues than RVXCF: NGNE (925K) vs RVXCF (0).
NGNERVXCFNGNE / RVXCF
Capitalization254M8.79M2,891%
EBITDA-49.96M-8.09M618%
Gain YTD-28.478-36.29978%
P/E RatioN/AN/A-
Revenue925K0-
Total Cash139M43K323,256%
Total Debt14.5M8.95M162%
FUNDAMENTALS RATINGS
NGNE vs RVXCF: Fundamental Ratings
NGNE
RVXCF
OUTLOOK RATING
1..100
2088
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6593
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVXCF's Valuation (29) in the null industry is somewhat better than the same rating for NGNE (64). This means that RVXCF’s stock grew somewhat faster than NGNE’s over the last 12 months.

RVXCF's Profit vs Risk Rating (100) in the null industry is in the same range as NGNE (100). This means that RVXCF’s stock grew similarly to NGNE’s over the last 12 months.

RVXCF's SMR Rating (100) in the null industry is in the same range as NGNE (100). This means that RVXCF’s stock grew similarly to NGNE’s over the last 12 months.

NGNE's Price Growth Rating (65) in the null industry is in the same range as RVXCF (93). This means that NGNE’s stock grew similarly to RVXCF’s over the last 12 months.

RVXCF's P/E Growth Rating (95) in the null industry is in the same range as NGNE (100). This means that RVXCF’s stock grew similarly to NGNE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NGNE
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
83%
Momentum
ODDS (%)
Bearish Trend 7 days ago
87%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
85%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+0.86%
BRNS - NGNE
50%
Loosely correlated
-4.12%
RNAZ - NGNE
48%
Loosely correlated
-2.60%
SNDX - NGNE
43%
Loosely correlated
-7.11%
ZNTL - NGNE
40%
Loosely correlated
-2.60%
BPTSY - NGNE
38%
Loosely correlated
N/A
More

RVXCF and

Correlation & Price change

A.I.dvisor tells us that RVXCF and FULC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and FULC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVXCF
1D Price
Change %
RVXCF100%
N/A
FULC - RVXCF
25%
Poorly correlated
+0.93%
TELIF - RVXCF
23%
Poorly correlated
-20.17%
ATNM - RVXCF
22%
Poorly correlated
+3.77%
NGNE - RVXCF
21%
Poorly correlated
+0.86%
IDYA - RVXCF
20%
Poorly correlated
-1.78%
More